Price $44.79 |
Market Cap
1.62B
|
Sector Health Care |
Div. Growth
-
|
|
P/E
-
|
P/B
10.86
|
P/S
6.02
|
Dividend %
-
|
|
P/CF
-
|
P/FCF
489.2
|
Op. Cash Flow
5.8K
|
FCF
0.0
|
|
Op. Margin
-1.50%
|
Net Margin
-1.20%
|
ROE
-2.20%
|
ROI
-0.60%
|
|
ROA
-1.50%
|
EPS Growth
-478.10%
|
Current Ratio
4.3
|
Debt/Equity
14.20%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Owens & Minor, Inc. (OMI) | $7.54 | - | 0.20% | 414.2M | Strong Buy |
| China Pharma Holdings, Inc. (CPHI) | $0.24 | - | - | 10.4M | Strong Buy |
| Assertio Therapeutics Inc (ASRT) | $0.71 | - | - | 63.3M | Strong Buy |
| Ocugen Inc (OCGN) | $0.41 | - | - | 5.7M | Strong Buy |
| Novelion Therapeutics Inc (USA (NVLNF) | $0.74 | - | - | 13.3M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
